Morgan Stanley upgraded Intuitive Surgical (ISRG) to Overweight from Equal Weight with a price target of $650, up from $522, as the analyst assumed coverage of the stock. The firm expects strong Davita 5 placements to drive upside to Street installed base expectations and its work on system payback curves points to a number of potential new areas like glioblastoma resection, hybrid cardiac revascularization and nipple sparing mastectomy, the analyst tells investors.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target raised to $561 from $535 at BTIG
- Trump Trade: President-elect seeks to kill Biden fuel-efficiency rules
- Workday initiated, Kraft Heinz downgraded: Wall Street’s top analyst calls
- Intuitive Surgical upgraded to Buy at Erste on ‘excellent market position’
- Intuitive Surgical upgraded to Buy from Hold at Erste Group